Photobiomodulation as an Adjunctive Treatment to Physiotherapy for Reduction of Anterior Knee Pain in Combat Soldiers: A Prospective, Double‐Blind, Randomized, Pragmatic, Sham‐Controlled Trial

التفاصيل البيبلوغرافية
العنوان: Photobiomodulation as an Adjunctive Treatment to Physiotherapy for Reduction of Anterior Knee Pain in Combat Soldiers: A Prospective, Double‐Blind, Randomized, Pragmatic, Sham‐Controlled Trial
المؤلفون: Roni Gofshtein, Lilach Gavish, Nathalie Folk, Arik Eisenkraft, Evgeny Fatale, Evgeny Gelman, Joseph Lowe, Yonaton Zarbiv, S. David Gertz, Yair Barzilay, Michael Herman, Lev Vishnevski, Elad Spitzer, Arnon Gam, Ilan Friedman
المصدر: Lasers in Surgery and Medicine. 53:1376-1385
بيانات النشر: Wiley, 2021.
سنة النشر: 2021
مصطلحات موضوعية: Male, medicine.medical_specialty, Visual analogue scale, Pain, Dermatology, 01 natural sciences, law.invention, 010309 optics, Double blind, 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, 0103 physical sciences, medicine, Humans, Prospective Studies, Low-Level Light Therapy, Lead (electronics), Physical Therapy Modalities, business.industry, Anterior knee pain, Outcome measures, Military Personnel, Adjunctive treatment, Physical therapy, Female, Surgery, business, Body mass index
الوصف: Background and objectives Anterior knee pain (AKP) is the most common knee pathology in athletes and occurs in 15% of army recruits of elite units during basic training. Of these, 50% are symptomatic 6 years later. Photobiomodulation (PBM) is a nonthermal red-to-near-infrared irradiation used for pain reduction of a variety of etiologies. This study was designed to determine whether addition of PBM to physiotherapy (PT) for AKP in combat soldiers is superior to PT alone. Study design/materials and methods In this prospective, double-blind, sham-controlled, randomized clinical trial (NCT02845869), 26 combat soldiers/policemen (male:female, 15:11; body mass index [BMI] = 24.2 ± 3.9, n = 46 knees), with AKP due to overuse/load, received 4 weeks of PT + sham (PT + Sham) or active PBM (wavelength = 660 and 850 nm, pulsing = 2.5 Hz, LED power = 50 mW/cm2 [local tissue/regional lymph nodes]; 810 nm continuous beam, laser cluster 6 W/cm2 [analgesia] and laser pointer 4.75 W/cm2 [trigger points]) (PT + PBM). The main outcome measures were subjective pain by visual analog scale (VAS) (0 [none]-100 [intolerable]) and functional disability by Kujala score (0 [worst]-100 [best]). Evaluations were carried out at baseline, end of treatments, and 3-month follow-up. Results All participants completed the treatment protocol without any reported adverse device effects. Post-treatment pain was significantly reduced in the PT+PBM group, compared with baseline and sham (Δpain, VAS, mean ± SD: PT + PBM = -19 ± 23, P = 0.002; PT + Sham = -6 ± 21, P = 0.16; between groups, P = 0.032). At 3-month follow-up, pain reduction was similar between groups; however, the Kujala score was significantly improved only in the PBM-treated group (ΔKujala: PT + PBM = 11 ± 10, P = 0.003; PT + Sham = 5 ± 7, P = 0.059). Conclusions Addition of PBM to PT for AKP resulted in earlier reduction in pain and improved functionality, compared with PT alone. This noninvasive, nonpharmacologic, adjunctive therapeutic modality can be easily incorporated into team healthcare frameworks or end units and may lead to earlier return to competition or combat-level service. Lasers Surg. Med. © 2021 Wiley Periodicals LLC.
تدمد: 1096-9101
0196-8092
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a05c56f94b3306d0a40cd64106b3d24eTest
https://doi.org/10.1002/lsm.23442Test
حقوق: CLOSED
رقم الانضمام: edsair.doi.dedup.....a05c56f94b3306d0a40cd64106b3d24e
قاعدة البيانات: OpenAIRE